Daily News Podcast

Cardiovascular risk with diclofenac


 

Diclofenac has emerged as a clear culprit in higher risk for adverse cardiovascular events. Also today, the majority of e-cigarette users are under 35 years of age, a hospital dropped length of stay for neonatal abstinence syndrome, and physician groups continue to call for CMS to drop evaluation and management proposal.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Breastfeeding linked with lower risk of stroke later in life
MDedge Cardiology
Rivaroxaban data abound at ESC 2018
MDedge Cardiology
New MI definition for infarction vs injury
MDedge Cardiology
Lorcaserin shows cardiovascular safety
MDedge Cardiology
Lung function decline linked to cardiovascular risk
MDedge Cardiology
ESC 2018 in review
MDedge Cardiology
Rivaroxaban beats aspirin for VTE
MDedge Cardiology
FDA approval for 2 HIV drugs
MDedge Cardiology
ATTR-ACT shows treatment breakthrough in amyloid cardiomyopathy
MDedge Cardiology
Modest alcohol and NAFLD
MDedge Cardiology